Ideos

Colecalciferol, the active ingredient in Ideos, is a Vitamin D3 and Calcium supplement presented as an oral tablet for oral use. It helps correct vitamin D and calcium deficiencies in adults.

GNH USA supplies Ideos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ideos, a vitamin D3 and calcium supplement, is used to manage conditions related to calcium and vitamin D metabolism.

Calcium deficiency: supports bone mineralisation and normal calcium levels. Vitamin D deficiency: enhances intestinal calcium absorption. Osteoporosis prevention: contributes to maintenance of bone density in at‑risk populations.

Common Side Effects: - Nausea or mild gastrointestinal upset. - Constipation or abdominal discomfort. - Flatulence or bloating. - Mild hypercalcaemia symptoms such as fatigue. - Headache.

Serious or Rare Side Effects: - Significant hypercalcaemia leading to kidney stones. - Allergic reactions including rash, itching or swelling. - Hypervitaminosis D with severe calcium overload. - Cardiac arrhythmias associated with high calcium levels. - Severe muscle weakness or confusion.

Before initiating Ideos, consider the following precautions. - Baseline assessment: check serum calcium and vitamin D status. - Renal function: monitor in patients with kidney disease. - Hypercalcaemia: avoid use in individuals with elevated calcium levels. - Granulomatous diseases: use cautiously in sarcoidosis or tuberculosis. - Dosage adherence: do not exceed the prescriber‑recommended amount. - Store at room temperature: keep in the original container, protect from moisture and light.

Ideos may interact with other medicines; review the following.

Major Interactions (Avoid): - Thiazide diuretics: can increase calcium retention and risk of hypercalcaemia. - Digitalis glycosides: heightened calcium levels may predispose to toxicity. - High‑dose vitamin A supplements: combined excess may cause hypervitaminosis D.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenytoin, phenobarbital): may accelerate vitamin D metabolism, reducing efficacy. - Glucocorticoids: can impair calcium absorption and increase bone loss. - Orlistat: may reduce absorption of fat‑soluble vitamins including vitamin D.